BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  4 Possible Biotech Takeover Targets for 2018

  This year wasn’t big for mergers and acquisitions in biopharma, particularly compared to 2015 and 2016.

  December 12, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Genetown

  Why This Massachusetts Synthetic Bio Startup Could be the Next Biotech Unicorn

  In investment jargon, a “unicorn” has at least two meanings.

  December 12, 2017

   · 

  3 min read

   · 

  Mark Terry
• Drug Development

  First Time Ever: Scientists Fix Huntington’s Protein Defect With Ionis Pharma Drug

  The success has prompted Roche to exercise its option to license the product, called IONIS-HTT(Rx), at a cost of $45 million.

  December 12, 2017

   · 

  1 min read
• 

  Drug Development

  Bay Area’s Aduro Biotech Throws in the Towel on CRS-207, Will Wind Down Trials

  The company is shuttering the program and focusing on other compounds in its pipeline after CRS-207 failed in studies.

  December 12, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Zoll Medical Wins Huge $400M From the DoD

  According to the DoD statement, the contract is for one year with five options to extend the contract for an additional year.

  December 12, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Should Teva Start Cutting at the Bottom or the Top?

  These are tough times for Teva.

  December 12, 2017

   · 

  1 min read
• 

  Business

  What You Need to Know About Prelude Fertility

  Prelude Fertility was founded in late 2016 by successful startup entrepreneur Martin Varsavsky with a $200M investment.

  December 12, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Sanofi’s Massive ‘Oops!’

  The company’s vaccine controversy could cause legal and image problems for years to come.

  December 12, 2017

   · 

  1 min read
• New Zealand Breast Center Chooses Sectra’s Imaging Solution

  Sectra has implemented its IT solution for breast imaging at St Marks Breast Centre in New Zealand.

  December 12, 2017

   · 

  1 min read
• BTG plc: Northwestern University Adopts Y90 TARE With TheraSphere as First-Line Treatment for HCC

  BTG today announced that following positive results of its 15-year experience between 2003 and 2017 with TheraSphere, Northwestern University, Illinois has adopted Y90 TARE with TheraSphere as the primary trans-arterial LRT for patients with hepatocellular carcinomalimited to the liver.

  December 12, 2017

   · 

  4 min read